United Pharmacy Partners (UPPI) has entered into 5-year collaboration agreement to provide both low and high PET radiopharmaceuticals to Novation.
In addition to providing low and high radioisotopes which are utilized for both diagnostic and therapeutic uses, UPPI will offer a host of support options including BioDose patient management system to members served by Novation including VHA, UHC and Provista.
Patient management BioDose system allows the technologists to capture key patient data, manage patient studies and electronically order/fax doses.
UPPI president Perry Polsinelli said, "UPPI is pleased to be able to help enhance the delivery of quality nuclear pharmacy services to ensure effective and efficient diagnostic outcomes for the patients these members serve."